Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 25, 2010
Paclitaxel plus bevacizumab in patients with chemosensitive relapsed small cell lung cancer: a safety, feasibility, and efficacy study from the Hoosier Oncology GroupShadia Jalal, Pablo Bedano, Lawrence Einhorn, et al.
Biological Research for Nursing|January 4, 2011
Evaluating the role of serotonin on neuropsychological function after breast cancer using acute tryptophan depletionDiane Von Ah, Todd Skaar, Fredrick Unverzagt, et al.
Breast Cancer Research and Treatment|August 25, 2012
Advanced cognitive training for breast cancer survivors: a randomized controlled trialDiane Von Ah, Janet S Carpenter, Andrew Saykin, et al.
Cancer Chemotherapy and Pharmacology|January 22, 2010
A phase I dose escalation and pharmacokinetic study of vatalanib (PTK787/ZK 222584) in combination with paclitaxel in patients with advanced solid tumorsE Gabriela Chiorean, Srikar Malireddy, Anne E Younger, et al.
Journal of Cancer Research and Clinical Oncology|April 8, 2023
Effects of immunosuppressive treatment on patient outcomes after immune checkpoint inhibitor-related gastrointestinal toxicityMalek Shatila, Weijie Ma, Yantong Cui, et al.
Current Breast Cancer Reports|August 16, 2021
Breast Cancer Disparities Through the Lens of the COVID-19 PandemicLisa Newman, Laura Fejerman, Tuya Pal, et al.
Cancer|March 22, 2017
Survival benefit needed to undergo chemotherapy: Patient and physician preferencesInes Vaz-Luis, Anne O'Neill, Karen Sepucha, et al.
Infection Control and Hospital Epidemiology|March 13, 2025
Assessing the safety of increased outpatient cephalosporin use following the modification of penicillin allergy cross-reactivity alertsBryan Schneider, Kelly M Percival, Anna M Rhinehart, et al.
Breast Cancer Research and Treatment|October 7, 2020
A dynamic portrait of adverse events for breast cancer patients: results from a phase II clinical trial of eribulin in advanced HER2-negative breast cancerOtto Metzger Filho, Anita Giobbie-Hurder, Nancy U Lin, et al.
Pageof 4